ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Sundwall Leaves Hatch to head HRSA; Terry Joins Damon Biotech; Irlin On Hunger Strike

September 12, 1986

DCT Contract Funds To Be 20 Percent less In FY 1986 Than In 1985; To Eliminate ‘Low Priority’ Contracts

February 14, 1986

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007